BioTears® Oral Gel Caps are designed to systemically address the root inflammatory cause and effects of dry eye. BioTears has been clinically suggested to improve the tear chemistry and the health of the ocular surface.
BioTears Oral Gel Caps contain the optimal blend of Omega 3 and Omega 6 essentials fatty acids, plus all the nutrient co-factors suggested to enhance the metabolic conversion associated with the tear-specific series one anti-inflammatory prostaglandin, PGE1. BioTears Oral Gel Caps also include nutrients that are suggested to appropriately inhibit the essential fatty acid arachidonic acid production of the COX2 enzyme, the pro-inflammatory prostaglandin PGE2, and Interleukin Il-6. In addition, BioTears Oral Gel Caps include nutrients that are suggested to modulate goblet cell/mucin production in both the stimulated and unstimulated tear, the lacrimal gland aqueous output, as well as the meibomian gland oil output, which is vital to the prevention of evaporative dry eyes. Finally, BioTears Oral Gel Caps contain APO-Lactoferrin, which is suggested to inhibit the growth of both viral and bacterial pathogens in the three-layer tear film, as well as Green Tea, which is suggested to modulate osmolarity and ocular surface tension, and curcumin to address ocular surface inflammation.*
Recommended dosage: Four oral capsules per-day; two with each morning and evening meal.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.